SEARCH

SEARCH BY CITATION

References

  • 1
    Xiang J, Wünschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL, Stapleton JT. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 2001; 345:707714.MEDLINE
  • 2
    Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, Goergen B, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001; 345:715724.MEDLINE
  • 3
    Piroth L, Bourgeois C, Dantin S, Waldner A, Grappin M, Portier H, Chavanet P. Hepatitis C virus (HCV) genotype does not appear to be a significant prognostic factor in HIV-HCV–coinfected patients. AIDS 1999; 13:523524.MEDLINE
  • 4
    Stosor V, Wolinsky S. GB virus C and mortality from HIV infection. N Engl J Med 2001; 345:761762.MEDLINE
  • 5
    Mosier DE, Chisari FV. GB virus C and mortality from HIV infection. N Engl J Med 2002; 346:377379.MEDLINE
  • 6
    Csatary KL, Telegdy L, Gergely P, Bodey B, Bakács T. Preliminary report of a controlled trial of MTH-68 virus vaccine treatment in acute B and C hepatitis: a phase II study. Anticanc Res 1998; 18:12791282.
  • 7
    Csatary KL, Schnabel R, Bakács T. Successful treatment of decompensated chronic viral hepatitis by bursal disease virus vaccine. Anticanc Res 1999; 19:629634.
  • 8
    Bakács T, Mehrishi JN. Intentional superinfection of decompensated chronic viral hepatitis by avian infectious bursal disease virus shows promise. Cancer Detection and Prevention 2002; (Symposium volume):S14.